Regulation mechanism of phagocytotic process in leukocytes by an actin-binding protein, p57, and immune diseases
肌动蛋白结合蛋白p57对白细胞吞噬过程的调节机制与免疫疾病
基本信息
- 批准号:10672064
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In the present study, intracellular translocation of the actin-binding protein, p57, in phagocytotic leukocytes and its mechanism were investigated. First, two anitbodies with defferent specificities were prepared for the detection of intracellular p57. Ingestion of opsonized zymosan (OpZ) in neutrophils began within 30 seconds of particle binding and forming phagosomes were enriched for both F-action and p57. However, F-actin and p57 were shed from nascent phagosomes once particle internalization was complete (【approximately equal】5 MINUTES). On the other hand, NADPH oxidase subunits p47phox and p67phox were also recruited to forming phagosomes and were retained on mature phagosomes for at least 15 minutes. These results suggest that p57 plays some role in the formation of phagosomes but not in the expression of mature phagosome function such as superoxide generation. Then, the mechanism of p57 shedding from phagosomes was investigated. Since it has been shown that protein phosphorylation plays a key role in the signaling pathway duraing phagocytosis, phosphorylation of p57 during phagocytosis was studies. Ingestion of OpZ induced a transient increase of p57 phosphorylation. The time of increased phosphorylation corresponded with that of p57 shedding from phagosome. To investigate which protein kinase is responsible for the shedding, effects of inhibitors of protein phosphorylation on it was studied. It was found that protein kinase C inhibitors suppressed the p57 shedding.
本研究探讨了肌动蛋白结合蛋白p57在吞噬性白细胞中的胞内转位及其机制。首先,制备了两种特异性不同的抗体,用于检测细胞内p57。中性粒细胞中调理酵母聚糖(OpZ)的摄入在颗粒结合的30秒内开始,形成的吞噬体富含F-作用和p57。然而,一旦颗粒内化完成,F-肌动蛋白和p57就会从新生的吞噬体中脱落([约等于]5 μ TES)。另一方面,NADPH氧化酶亚基p47 phox和p67 phox也被募集以形成吞噬体,并在成熟的吞噬体上保留至少15分钟。这些结果表明,p57在吞噬体的形成中起一定的作用,但在成熟的吞噬体功能,如超氧化物的产生的表达中没有作用。然后,研究了p57从吞噬体脱落的机制。由于蛋白质磷酸化在吞噬过程中的信号转导途径中起着关键作用,因此研究了吞噬过程中p57的磷酸化。摄入OpZ诱导p57磷酸化的瞬时增加。磷酸化增加的时间与p57从吞噬体脱落的时间相对应。为了研究哪种蛋白激酶负责脱落,研究了蛋白磷酸化抑制剂对其的影响。发现蛋白激酶C抑制剂抑制p57脱落。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakajin, S.: "An NADPH-dependent reductase in neonatal pig testis that metabolizes androgens and xenobioics"Biol. Pharm. Bull.. 21. 1356-1360 (1998)
Nakajin, S.:“新生猪睾丸中一种 NADPH 依赖性还原酶,可代谢雄激素和异生素”Biol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yamaguchi, M.: "Acetylleucine chloromethyl ketone, an inhibitor of acylpeptide hydrolase, induces apoptosis of U937 cells"Biochem. Biophys. Res. Commun.. 263. 139-142 (1999)
Yamaguchi, M.:“乙酰亮氨酸氯甲基酮,酰基肽水解酶的抑制剂,诱导 U937 细胞凋亡”Biochem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hirohata. S.: "Association of serum IgG antibodies to recombinant ribosomal PO fusion protein with neuropsychiatric systemic lupus erythematosus"Arthritis Rheum.. 41 (4). 745-747 (1998)
广畑。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kosuge, T.: "Effect of inhibitors of glycoprotein processing on cytokine secretion and production in anti CD3-stimulated T cells"Biol. Pharm. Bull.. 23 (1). 1-5 (1000)
Kosuge, T.:“糖蛋白加工抑制剂对抗 CD3 刺激 T 细胞中细胞因子分泌和产生的影响”Biol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yamaguchi,M.: "Acetylleucine chloromethyl ketone,an inhibitor of acylpetide hydrolase,induces apoptosis of U937 cells"Biochem.Biophys.Res.Commun.. 263. 139-142 (1999)
Yamaguchi,M.:“乙酰亮氨酸氯甲基酮,酰肽水解酶抑制剂,诱导 U937 细胞凋亡”Biochem.Biophys.Res.Commun.. 263. 139-142 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TOYOSHIMA Satoshi其他文献
TOYOSHIMA Satoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TOYOSHIMA Satoshi', 18)}}的其他基金
Regulation of lymphocyte phospholipase C activity by a low molecular weight GTP-binding protein and its physiological role
低分子量GTP结合蛋白对淋巴细胞磷脂酶C活性的调节及其生理作用
- 批准号:
02670990 - 财政年份:1990
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Properties of physiological roles of a GTP-binding protein which is associated physically and functionally with phospholipase C
与磷脂酶 C 物理和功能相关的 GTP 结合蛋白的生理作用特性
- 批准号:
63571036 - 财政年份:1988
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
精神分裂症特异微小RNA的筛选、鉴定及其靶向调控功能研究
- 批准号:81000583
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Fibroblast-mediated inflammatory resolution of rheumatoid arthritis
成纤维细胞介导的类风湿性关节炎炎症消退
- 批准号:
10604629 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
The role of human SLE causal variant NCF1.pR90H in promoting kidney damage
人类SLE致病变异NCF1.pR90H在促进肾脏损伤中的作用
- 批准号:
10740630 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Cellular and molecular mechanisms involving SLAMF1 during pulmonary fungal infection
肺部真菌感染过程中涉及SLAMF1的细胞和分子机制
- 批准号:
10738468 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Bone Marrow Functions of Novel Pro-Resolving Mediators
新型亲解决介质的骨髓功能
- 批准号:
10852343 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
- 批准号:
10674221 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
CD11c as a novel target to improve neutrophil effector functions and sepsis outcome
CD11c 作为改善中性粒细胞效应功能和脓毒症结局的新靶点
- 批准号:
10552923 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Next-generation nanomedicine for acute ischemic stroke
治疗急性缺血性中风的下一代纳米药物
- 批准号:
10603229 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Autosomal dominant OTULIN deficiency and staphylococcal disease
常染色体显性 OTULIN 缺乏症和葡萄球菌病
- 批准号:
10373489 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:














{{item.name}}会员




